Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis. (PubMed, Medicine (Baltimore)) - Feb 16, 2024 - "In this meta-analysis, it should be that full vaccination with ACVs has high efficacy against Alpha or Gamma variants and moderate efficacy against Beta and Delta variants. Notably, with the exception of the aluminum-adjuvanted vaccine, the other ACVs had moderate to high efficacy against the SARS-CoV-2 variant. This raises concerns about the effectiveness of ACVs booster vaccinations against Omicron."
Journal • Retrospective data • Review • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|
|
Gao Song; Meng-Qun Cheng; Rong Li; Zhi-Ying Weng
|